CJ
Jandus, Camilla
Affiliation entities
Research groups
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | 2024 | 490 | 104 | |||
Methionine oxidation selectively enhances T cell reactivity against a melanoma antigen | iScience | 2023 | 137 | 62 | |||
Assessing the impact of persistent HIV infection on innate lymphoid cells using in vitro models | ImmunoHorizons | 2023 | 88 | 104 | |||
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability | Frontiers in immunology | 2023 | 71 | 23 | |||
Dendritic cells direct circadian anti-tumour immune responses | Nature | 2023 | 606 | 146 | |||
Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations | iScience | 2023 | 94 | 25 | |||
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia | Haematologica | 2023 | 62 | 25 | |||
High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arrays | Nature biomedical engineering | 2023 | 71 | 72 | |||
Dampening of cytotoxic innate lymphoid cells: A new tumour immune escape mechanism in B cell non-Hodgkin's lymphoma | Cellular immunology | 2022 | 198 | 88 | |||
Gliadin-reactive vitamin D-sensitive proinflammatory ILCPs are enriched in celiac patients | Cell reports | 2022 | 193 | 107 | |||
The era of cytotoxic CD4 T cells | Frontiers in immunology | 2022 | 146 | 209 | |||
Development of human ILCs and impact of unconventional cytotoxic subsets in the pathophysiology of inflammatory diseases and cancer | Frontiers in immunology | 2022 | 186 | 192 | |||
Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et) | Frontiers in medicine | 2022 | 177 | 84 | |||
c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells | EMBO journal | 2022 | 299 | 230 | |||
Static adhesion assay for human peripheral blood mononuclear cells | Bio-protocol | 2022 | 193 | 89 | |||
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions | Nature Communications | 2021 | 272 | 158 | |||
Healthy and patient type 2 innate lymphoid cells are differently affected by in vitro culture conditions | Journal of Asthma and Allergy | 2021 | 189 | 67 | |||
Immune checkpoint and telomerase crosstalk is mediated by miRNA-138 in bladder cancer | Frontiers in oncology | 2021 | 249 | 71 | |||
Editorial: memory T cells in chronic infections and tumors | Frontiers in Immunology | 2021 | 158 | 66 | |||
c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells | Cellular & Molecular Immunology | 2021 | 222 | 152 | |||
A new workflow combining magnetic cell separation and impedance-based cell dispensing for gentle, simple and reliable cloning of specific CD8+ T cells | SLAS technology | 2021 | 190 | 123 | |||
Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment | Cellular & Molecular Immunology | 2021 | 178 | 89 | |||
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer | Science Advances | 2021 | 400 | 125 | |||
Human primed ILCPs support endothelial activation through NF-κB signaling | eLife | 2021 | 289 | 82 | |||
Sharpening of peripersonal space during the COVID-19 pandemic | Current Biology | 2021 | 170 | 130 | |||
Impact of immunotherapy on CD4 T cell phenotypes and function in cancer | Vaccines | 2021 | 202 | 105 | |||
Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients | Journal for immunotherapy of cancer | 2020 | 437 | 259 | |||
Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells | Journal of Leukocyte Biology | 2020 | 334 | 201 | |||
Detecting and analyzing murine innate lymphoid cells | Tumor Immunology and Immunotherapy: Cellular Methods Part A | 2020 | 263 | 0 | |||
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion | Nature Immunology | 2020 | 355 | 1 | |||
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosus | Scientific Reports | 2020 | 273 | 114 | |||
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors | Nature Immunology | 2020 | 386 | 7 | |||
Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment | Cell Stress | 2020 | 278 | 113 | |||
Immunosuppressive mediators impair proinflammatory innate lymphoid cell function in human malignant melanoma | Cancer Immunology Research | 2020 | 429 | 4 | |||
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes | Cancers | 2020 | 294 | 150 | |||
The pro- and anti-tumor role of ILC2s | Seminars in Immunology | 2019 | 261 | 0 | |||
MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma | Cancer Immunology Research | 2019 | 203 | 1 | |||
ILC2s: new actors in tumor immunity | Frontiers in Immunology | 2019 | 307 | 105 | |||
High-throughput screening of human tumor antigen-specific CD4 T cells, including neoantigen-reactive T cells | Clinical Cancer Research | 2019 | 320 | 4 | |||
Immunophenotyping of human innate lymphoid cells | Methods in Molecular Biology | 2019 | 251 | 1 | |||
Peripheral innate lymphoid cells are increased in first line metastatic colorectal carcinoma patients: a negative correlation with th1 immune responses | Frontiers in Immunology | 2019 | 242 | 99 | |||
To be a tumor promoting or tumor suppressing ILC: that is the question | Seminars in Immunology | 2019 | 239 | 3 | |||
Lymphocyte-derived exosomal microRNAs promote pancreatic β cell death and may contribute to type 1 diabetes development | Cell Metabolism | 2019 | 259 | 3 | |||
The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies | Blood | 2019 | 281 | 3 | |||
Siglec-9 regulates an effector memory CD8+ T-cell subset that congregates in the melanoma tumor microenvironment | Cancer Immunology Research | 2019 | 222 | 0 | |||
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes | Nature Biotechnology | 2019 | 330 | 2 | |||
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML | Blood Advances | 2019 | 406 | 209 | |||
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells | Journal for Immunotherapy of Cancer | 2019 | 274 | 108 | |||
Human innate lymphoid cells (ILCs): Toward a uniform immune-phenotyping | Cytometry. Part B, Clinical cytometry | 2018 | 328 | 107 | |||
Innate lymphoid cells in antitumor immunity | Journal of Leukocyte Biology | 2018 | 217 | 0 | |||
Induction of paracrine signaling in metastatic melanoma cells by PPARγ agonist rosiglitazone activates stromal cells and enhances tumor growth | Cancer Research | 2018 | 267 | 0 | |||
Autocrine adenosine regulates tumor polyfunctional CD73+CD4+ effector T cells devoid of immune checkpoints | Cancer Research | 2018 | 256 | 0 | |||
Inhibition of membrane-bound BAFF by the anti-BAFF antibody belimumab | Frontiers in Immunology | 2018 | 262 | 112 | |||
ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells | Frontiers in Immunology | 2017 | 224 | 120 | |||
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis | OncoImmunology | 2017 | 261 | 0 | |||
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence | Journal of Clinical Investigation | 2017 | 283 | 132 | |||
Dysregulated Innate Lymphocytes in Patients With Primary Antibody Deficiency Treated With Intravenous Immunoglobulin | Journal of Investigational Allergology and Clinical Immunology | 2017 | 416 | 1 | |||
Identification of innate lymphoid cells in single-cell RNA-Seq data | Immunogenetics | 2017 | 265 | 3 | |||
The vast universe of T cell diversity: subsets of memory cells and their differentiation | Methods in Molecular Biology | 2017 | 260 | 0 | |||
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis | Nature Communications | 2017 | 453 | 127 | |||
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions | Nature Communications | 2016 | 245 | 77 | |||
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope | OncoImmunology | 2016 | 252 | 1 | |||
Modulation of mTOR signalling triggers the formation of stem cell-like memory T cells | EBioMedicine | 2016 | 287 | 105 | |||
Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts | Cancer research | 2009 | 584 | 0 |